Let's say some policies are changed in EU and pharmaceutical companies make as much or more profit in EU as in US - do you think they will reduce the cost of drugs in US? Perhaps not - remember they have shareholders. They probably aren't going to say, "oh! we have made enough money on this drug. Let's reduce the price now.".